Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic polymorphisms and efficacy/safety of oral paliperidone in Chinese Han patients with schizophrenia
ChiCTR2100048320Phase 4Not yet recruiting
- Sponsor
- Peking University Sixth Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of paliperidone in schizophrenia, sponsored by Peking University Sixth Hospital. Primary endpoints: Positive and Negative Syndrome Scale (PANSS) and Gene data (candidate gene polymorphisms). Planned start Sep 2021; status: not yet recruiting.
02
Drugs
paliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR2100048320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048320.